BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 33964490)

  • 21. Combined assessment of muscle quality and quantity predicts oncological outcome in patients with esophageal cancer.
    Kitajima T; Okugawa Y; Shimura T; Yamashita S; Sato Y; Goel A; Mizuno N; Yin C; Uratani R; Imaoka H; Morimoto Y; Kawamura M; Mochiki I; Okita Y; Yokoe T; Ohi M; Toiyama Y
    Am J Surg; 2023 Jun; 225(6):1036-1044. PubMed ID: 36462959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.
    Ueki H; Hara T; Okamura Y; Bando Y; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
    Investig Clin Urol; 2022 Jul; 63(4):415-424. PubMed ID: 35796138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
    BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple Age Specific Cutoff Value for Sarcopenia Evaluated by Computed Tomography.
    Kim JS; Kim WY; Park HK; Kim MC; Jung W; Ko BS
    Ann Nutr Metab; 2017; 71(3-4):157-163. PubMed ID: 28881338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcopenia as a Predictor of Survival Among Patients With Organ Metastatic Cervical Cancer.
    Yoshikawa N; Shirakawa A; Yoshida K; Tamauchi S; Suzuki S; Kikkawa F; Kajiyama H
    Nutr Clin Pract; 2020 Dec; 35(6):1041-1046. PubMed ID: 32253779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring sarcopenia on pre-operative CT in older adults undergoing emergency laparotomy: a comparison of three different calculations.
    Simpson G; Manu N; Magee C; Wilson J; Moug S; Vimalachandran D
    Int J Colorectal Dis; 2020 Jun; 35(6):1095-1102. PubMed ID: 32215679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy.
    Ishida T; Makino T; Yamasaki M; Yamashita K; Tanaka K; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Eguchi H; Doki Y
    Ann Surg Oncol; 2021 Nov; 28(12):7185-7195. PubMed ID: 33876359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
    Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
    World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies.
    Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Kobayashi A; Iida T; Yagi S; Taura K; Hatano E; Uemoto S
    Surgery; 2016 Mar; 159(3):821-33. PubMed ID: 26603849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
    BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis.
    Wang P; Wang S; Li X; Lin G; Ma Y; Xiao R; Li H; Qiu M; Yang F
    Int J Surg; 2022 Jan; 97():106206. PubMed ID: 34990833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-operative psoas muscle index, a surrogate for sarcopenia; as a predictor of post-esophagectomy complications.
    Yunrong T; Jin WW; Mahendran HA; Koon YB; Jahit S; Kamaruddin MA; Anuar N; Daud NAM
    Dis Esophagus; 2024 Apr; 37(4):. PubMed ID: 38163959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
    Chakedis J; Spolverato G; Beal EW; Woelfel I; Bagante F; Merath K; Sun SH; Chafitz A; Galo J; Dillhoff M; Cloyd J; Pawlik TM
    J Gastrointest Surg; 2018 Oct; 22(10):1697-1708. PubMed ID: 29855867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of preoperative total psoas muscle area on long-term outcome in surgically treated oesophageal cancer patients.
    Park SY; Yoon JK; Lee SJ; Haam S; Jung J
    Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):13-19. PubMed ID: 27587471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.
    Kayano H; Nomura E; Abe R; Ueda Y; Machida T; Fujita C; Uchiyama S; Endo K; Murakami K; Mukai M; Makuuchi H
    BMC Surg; 2019 Nov; 19(1):181. PubMed ID: 31779610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased total psoas muscle area after neoadjuvant therapy is a predictor of increased mortality in patients undergoing oesophageal cancer resection.
    Yassaie SS; Keane C; French SJH; Al-Herz FAJ; Young MK; Gordon AC
    ANZ J Surg; 2019 May; 89(5):515-519. PubMed ID: 30959566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer.
    Kita R; Miyata H; Sugimura K; Tanaka K; Makino T; Yamashita K; Yamasaki M; Motoori M; Shiraishi O; Kimura Y; Yasuda T; Yano M; Doki Y
    Clin Nutr; 2021 Jun; 40(6):4380-4385. PubMed ID: 33526287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
    Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
    J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT anthropometric analysis of the prognosis of traumatic brain injury: A retrospective study to compare between psoas muscle and abdominal skeletal muscle.
    Cho HJ; Hwang Y; Yang SY; Kim M
    Injury; 2022 May; 53(5):1652-1657. PubMed ID: 35241285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Relationship between Sarcopenia and Survival after Cabazitaxel Treatment for Castration-Resistant Prostate Cancer].
    Onishi K; Tanaka N; Hori S; Nakai Y; Miyake M; Anai S; Fujimoto K
    Hinyokika Kiyo; 2022 Jul; 68(7):217-225. PubMed ID: 35924704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.